Medi-Globe Corporation

Medi-Globe Corporation specializes in single-use medical devices primarily used in endoscopic and procedural applications. Their portfolio includes general-purpose and body aspiration needles, flexible polypectomy snares, ultrasound-guided aspiration biopsy procedure kits, endoscopic injection needles (like the Injectra and ScleroTip series), and surgical suction system collection containers. These devices are designed for precision in procedures such as biopsies, polypectomies, and injections, often leveraging ultrasound or endoscopic guidance.

Medi-Globe Corporation is based in the United States, which means its devices fall under FDA regulatory jurisdiction. Since the company’s products are classified as Class II devices in the US, they are subject to the FDA’s 510(k) premarket notification process and must comply with UDI (Unique Device Identifier) requirements. This classification indicates moderate regulatory scrutiny, as these devices pose a lower risk compared to Class III but still require validation of safety and performance.

Medi-Globe Corporation’s devices are listed in the FDA’s 510(k) registry, which documents premarket submissions for Class II devices, and the FDA’s Unique Device Identifier (UDI) database. The UDI system ensures traceability and transparency in the supply chain, while the 510(k) registry reflects the company’s compliance with FDA requirements for device authorization. These registries help healthcare providers and regulators verify the legitimacy and regulatory status of the devices.

Medi-Globe Corporation’s devices are classified as Class II under FDA regulations. This classification means they are considered to have a moderate risk and require special controls beyond general controls (like good manufacturing practices) to ensure their safety and effectiveness. While they don’t require the stringent premarket approval process of Class III devices, they still undergo 510(k) clearance to demonstrate substantial equivalence to a predicate device. This classification balances regulatory oversight with operational feasibility for manufacturers and users.

Listing in the FDA’s UDI (Unique Device Identifier) registry means each of Medi-Globe Corporation’s devices carries a standardized identifier that includes a device identifier (DI) and a production identifier (PI). This system improves tracking, reduces medical errors, and enhances supply chain transparency by ensuring devices can be uniquely traced from manufacturing to patient use. For healthcare providers, UDIs enable better inventory management and recall coordination, while for regulators, they facilitate post-market surveillance and compliance monitoring.